MRPL40 Polyclonal Antibody
€0.00
In stock
SKU
E-AB-19169
Catalog Number: E-AB-19169
Isotype: Rabbit IgG
Reactivity: human
Applications: WB,IHC,ELISA
Datasheet, Questions? Contact us!
Isotype: Rabbit IgG
Reactivity: human
Applications: WB,IHC,ELISA
Datasheet, Questions? Contact us!
Background:
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Deletions in this gene may contribute to the etiology of velo-cardio-facial syndrome and DiGeorge syndrome.MRPL40 (Mitochondrial Ribosomal Protein L40) is a Protein Coding gene. Diseases associated with MRPL40 include Mrpl40-Related Disorder and Velocardiofacial Syndrome. Among its related pathways are Mitochondrial translation and Organelle biogenesis and maintenance. GO annotations related to this gene include poly(A) RNA binding.
Research Area: Epigenetics and Nuclear Signaling, Metabolism
Synonyms:
39S ribosomal protein L40, 39S ribosomal protein L40 mitochondrial, 39S ribosomal protein L40, mitochondrial precursor, FLJ41774, L40mt, MGC9400, mitochondrial, Mitochondrial ribosomal protein L40, MRP 40, MRP L22, MRP-L40, MRP40, MRPL22, MRPL40, NLVCF, Nuclear localization signal containing protein deleted in velocardiofacial syndrome, Nuclear localization signal deleted in velocardiofacial syndrome, Nuclear localization signal-containing protein deleted in velocardiofacial syndrome, RM40, Up-regulated in metastasis, URIM
Immunogen: Fusion protein of human MRPL40
Swissprot: Q9NQ50
Gene Accession: BC009707
Calculated MW: 24 kDa
Observed MW: Refer to figures
Purification Method: Antigen affinity purification
Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Concentration: 1.44 mg/mL
Dilution: WB 1:1000-1:5000, IHC 1:100-1:300, ELISA 1:5000-1:10000
Storage:
Store at -20°C. Avoid freeze / thaw cycles.
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Deletions in this gene may contribute to the etiology of velo-cardio-facial syndrome and DiGeorge syndrome.MRPL40 (Mitochondrial Ribosomal Protein L40) is a Protein Coding gene. Diseases associated with MRPL40 include Mrpl40-Related Disorder and Velocardiofacial Syndrome. Among its related pathways are Mitochondrial translation and Organelle biogenesis and maintenance. GO annotations related to this gene include poly(A) RNA binding.
Research Area: Epigenetics and Nuclear Signaling, Metabolism
Synonyms:
39S ribosomal protein L40, 39S ribosomal protein L40 mitochondrial, 39S ribosomal protein L40, mitochondrial precursor, FLJ41774, L40mt, MGC9400, mitochondrial, Mitochondrial ribosomal protein L40, MRP 40, MRP L22, MRP-L40, MRP40, MRPL22, MRPL40, NLVCF, Nuclear localization signal containing protein deleted in velocardiofacial syndrome, Nuclear localization signal deleted in velocardiofacial syndrome, Nuclear localization signal-containing protein deleted in velocardiofacial syndrome, RM40, Up-regulated in metastasis, URIM
Immunogen: Fusion protein of human MRPL40
Swissprot: Q9NQ50
Gene Accession: BC009707
Calculated MW: 24 kDa
Observed MW: Refer to figures
Purification Method: Antigen affinity purification
Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Concentration: 1.44 mg/mL
Dilution: WB 1:1000-1:5000, IHC 1:100-1:300, ELISA 1:5000-1:10000
Storage:
Store at -20°C. Avoid freeze / thaw cycles.
| Is Featured? | No |
|---|
Write Your Own Review